These results, along with a former report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the strategy of focusing on ACKR3 as a novel way to modulate the opioid method, which could open up new therapeutic avenues for opioid-connected disorders.Importantly, these receptors were found to are al